Touraj Mansourbakht
Overview
Explore the profile of Touraj Mansourbakht including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
300
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barret M, Antoun S, Dalban C, Malka D, Mansourbakht T, Zaanan A, et al.
Nutr Cancer
. 2014 Apr;
66(4):583-9.
PMID: 24707897
Chemotherapy toxicity could be linked to decreased skeletal muscle (sarcopenia). We evaluated the effect of sarcopenia on chemotherapy toxicity among metastatic colorectal cancer (mCRC) patients. All consecutive mCRC patients in...
2.
Zaanan A, Williet N, Hebbar M, Dabakuyo T, Fartoux L, Mansourbakht T, et al.
J Hepatol
. 2012 Sep;
58(1):81-8.
PMID: 22989572
Background & Aims: The current standard treatment for advanced hepatocellular carcinoma (HCC) is sorafenib. This drug is effective but generally does not induce tumor shrinkage and other treatment options are...
3.
Barret M, Malka D, Aparicio T, Dalban C, Locher C, Sabate J, et al.
Oncology
. 2012 Jan;
81(5-6):395-402.
PMID: 22269999
Background: The possible impact of malnutrition on the tolerability and efficacy of modern chemotherapy regimens for metastatic colorectal cancer (mCRC) is unclear. Methods: In this prospective, cross-sectional, multicenter study, we...
4.
Louafi S, Boige V, Ducreux M, Bonyhay L, Mansourbakht T, De Baere T, et al.
Cancer
. 2007 Mar;
109(7):1384-90.
PMID: 17330837
Background: New systemic therapies are needed to improve the prognosis of patients with advanced-stage hepatocellular carcinoma (HCC). In a Phase II trial involving previously untreated patients with advanced HCC, the...
5.
Louafi S, Mansourbakht T, Bonyhay L, Taieb J
Bull Cancer
. 2006 Feb;
93 Suppl 1:S23-33.
PMID: 16483942
In a few years, oxaliplatin became a standard treatment of colorectal cancer not only in metastatic situation but also in the adjuvant setting. In the others gastro-intestinal malignancies such as...
6.
Botton E, Saraux A, Malhaire J, Mansourbakht T, Jousse S, Le Goff P, et al.
Joint Bone Spine
. 2004 Jun;
71(3):230-3.
PMID: 15182796
Post-fracture osteolysis of the pubic bone is rare. We report a case of a 70-year-old woman with osteoporosis and a history of radiation therapy 2 years earlier. At presentation, she...
7.
Taieb J, Bonyhay L, Golli L, Ducreux M, Boleslawski E, Tigaud J, et al.
Cancer
. 2003 Dec;
98(12):2664-70.
PMID: 14669287
Background: New therapies are needed to improve the prognosis of patients with advanced hepatocellular carcinoma (HCC). Various gemcitabine-oxaliplatin combinations have been tested recently in patients with ovarian and pancreatic carcinoma,...